Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-12 4:14 pm Sale |
2023-12-31 | 13G | BioPlus Acquisition Corp. BIOS |
CANTOR FITZGERALD SECURITIES | 0 0.000% |
-1,602,204 (Position Closed) |
Filing History |
| 2024-02-09 10:26 am Sale |
2023-12-31 | 13G | BioPlus Acquisition Corp. BIOS |
Polar Asset Management Partners Inc. | 0 0.000% |
-1,189,211 (Position Closed) |
Filing History |
| 2024-02-07 2:00 pm Sale |
2023-12-31 | 13G | BioPlus Acquisition Corp. BIOS |
Saba Capital Management, L.P. | 0 0.000% |
-1,791,845 (Position Closed) |
Filing History |
| 2024-01-19 3:46 pm Sale |
2023-12-31 | 13G | BioPlus Acquisition Corp. BIOS |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 0 0.000% |
-1,482,836 (Position Closed) |
Filing History |
| 2023-06-12 9:44 pm Unchanged |
2023-06-02 | 13D | BioPlus Acquisition Corp. BIOS |
BioPlus Sponsor LLC | 6,630,000 34.200% |
0 (Unchanged) |
Filing History |
| 2023-02-14 3:38 pm Purchase |
2022-12-31 | 13G | BioPlus Acquisition Corp. BIOS |
CANTOR FITZGERALD SECURITIES | 1,602,204 6.800% |
350,375 (+27.99%) |
Filing History |
| 2023-02-14 06:13 am Purchase |
2022-12-31 | 13G | BioPlus Acquisition Corp. BIOS |
Saba Capital Management, L.P. | 1,791,845 7.600% |
1,791,845 (New Position) |
Filing History |
| 2023-02-09 3:01 pm Purchase |
2022-12-31 | 13G | BioPlus Acquisition Corp. BIOS |
Polar Asset Management Partners Inc. | 1,189,211 5.050% |
1,189,211 (New Position) |
Filing History |
| 2023-02-02 10:10 am Purchase |
2022-12-31 | 13G | BioPlus Acquisition Corp. BIOS |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,482,836 6.290% |
1,482,836 (New Position) |
Filing History |
| 2022-11-02 5:25 pm Purchase |
2022-10-27 | 13G | BioPlus Acquisition Corp. BIOS |
CANTOR FITZGERALD SECURITIES | 1,251,829 5.310% |
1,251,829 (New Position) |
Filing History |
| 2022-02-14 06:59 am Purchase |
2021-12-31 | 13G | BioPlus Acquisition Corp. BIOSU |
Saba Capital Management, L.P. | 1,500,000 6.400% |
200,000 (+15.38%) |
Filing History |
| 2022-02-09 2:14 pm Sale |
2021-12-31 | 13G | BioPlus Acquisition Corp. BIOSU |
MMCAP International Inc. SPC | 650,000 3.160% |
-350,000 (-35.00%) |
Filing History |
| 2021-12-17 4:46 pm Purchase |
2021-12-07 | 13D | BioPlus Acquisition Corp. BIOS |
BioPlus Sponsor LLC | 6,630,000 22.400% |
6,630,000 (New Position) |
Filing History |
| 2021-12-13 2:43 pm Purchase |
2021-12-03 | 13G | BioPlus Acquisition Corp. BIOSU |
Saba Capital Management, L.P. | 1,300,000 5.500% |
1,300,000 (New Position) |
Filing History |
| 2021-12-10 5:19 pm Purchase |
2021-12-06 | 13G | BioPlus Acquisition Corp. BIOSU |
MMCAP International Inc. SPC | 1,000,000 5.000% |
1,000,000 (New Position) |
Filing History |
| 2021-12-10 08:40 am Purchase |
2021-12-02 | 13G | BioPlus Acquisition Corp. BIOSU |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,051,735 4.460% |
1,051,735 (New Position) |
Filing History |